APA (7th ed.) Citation

M, B., DP, G., B, C., S, F., B, M., S, P., . . . P, R. (2026). The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients. EMBO molecular medicine, 18(5), 1551. https://doi.org/10.1038/s44321-026-00408-6

Chicago Style (17th ed.) Citation

M, Bilusic, et al. "The Anti-obesogenic Metabolite, Lac-Phe, Is Elevated by Metformin Treatment in Prostate Cancer Patients." EMBO Molecular Medicine 18, no. 5 (2026): 1551. https://doi.org/10.1038/s44321-026-00408-6.

MLA (9th ed.) Citation

M, Bilusic, et al. "The Anti-obesogenic Metabolite, Lac-Phe, Is Elevated by Metformin Treatment in Prostate Cancer Patients." EMBO Molecular Medicine, vol. 18, no. 5, 2026, p. 1551, https://doi.org/10.1038/s44321-026-00408-6.